CEO: Ted W. Love

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.


Key numbers

Market Capitalization:3081417960
Shares Outstanding: 60231000
Float: 58516524.585
Next Earning Date:2020-02-26
TTm EPS: -3.8867
TTm Dividend Rate:
200 days moving average:52.99
50 days moving average: 49.76
One day percent Change: 8.74



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,